Purpose: To retrospectively review all patients undergoing late open conversion (LOC) after endovascular aneurysm repair (EVAR) in order to identify any clinical or technical predictors of poor outcome. Methods: Twenty-six consecutive patients (24 men; mean age 74.7±8.3 years) underwent LOC between June 2006 and April 2013 at our institution. The mean interval from index EVAR to LOC was 40.4±29.2 months (range 5–93 months). The indication for LOC was endoleak in 14 (54%) patients and infection in 12 (46%): 2 (8%) patients with endoleak had a ruptured aneurysm and 6 (23%) patients with infection had a recurrent secondary aortoesophageal fistula (sAEF). Results: In all 12 cases of infection and in 12 of 14 endoleaks, the entire endograft was explanted. A rifampin-soaked Dacron silver graft was implanted in all patients with infection. Patients with any infection and with recurrent AEF required more blood units than patients with endoleak (6.40 vs. 1.86, p=0.045; 6.76 vs. 1.86, p=0.0036, respectively). Compared with endoleak, the duration of conversions in the setting of infection (274 vs. 316 minutes, p=0.42) and recurrent sAEF (274 vs. 396 minutes, p=0.021) was longer. All patients with recurrent sAEF died at a mean 3.0±2.5 days after LOC from proximal anastomosis disruption and hemorrhagic shock (n=2), myocardial infarction (n=2), acute stroke (n=1), or persistent sepsis (n=1). Perioperative mortality was significantly higher in patients with endograft infection (6/12, p=0.002) and in cases of supraceliac cross-clamping (4/6, p=0.003). The association of infection with supraceliac cross-clamping was a strong predictor for perioperative mortality (p<0.001). Conclusion: In our experience, endograft infection led to greater perioperative mortality after LOC. Recurrent aortoenteric fistula in association with supraceliac cross-clamping is a strong predictor of poor outcome. Patients surviving the perioperative period may have good chances of long-term survival.
KlonarisCLioudakiSKatsargyrisA. Late open conversion after failed endovascular aortic aneurysm repair. J Vasc Surg. 2014;59:291–297.
2.
ChaikofELBrewsterDCDalmanRL. The care of patients with an abdominal aortic aneurysm: the Society for Vascular Surgery practice guidelines. J Vasc Surg. 2009;50(4 suppl):S2–S49.
3.
BrinsterCJFairmanRMWooEY. Late open conversion and explantation of abdominal aortic stent grafts. J Vasc Surg. 2011;54:42–46.
4.
GreenhalghRMBrownLCKwongGP. Comparison of endovascular aneurysm repair with open repair in patients with abdominal aortic aneurysm (EVAR trial 1), 30-day operative mortality results: randomised controlled trial. Lancet. 2004;364:843–848.
5.
HoboRButhJ. Secondary interventions following endovascular abdominal aortic aneurysm repair using current endografts. A EUROSTAR report. J Vasc Surg. 2006;43:896–902.
6.
HarrisPLVallabhaneniSRDesgrangesP. Incidence and risk factors of late rupture, conversion, and death after endovascular repair of infrarenal aortic aneurysms: the EUROSTAR experience. J Vasc Surg. 2000;32:739–749.
7.
SampramESKarafaMTMaschaEJ. Nature, frequency, and predictors of secondary procedures after endovascular repair of abdominal aortic aneurysm. J Vasc Surg. 2003;37:930–937.
8.
GreenbergRKChuterTASternberghWC3rd. Zenith AAA endovascular graft: intermediate-term results of the US multicenter trial. J Vasc Surg. 2004;39:1209–1218.
9.
PetersonBGMatsumuraJSBrewsterDC. Excluder Bifurcated Endoprosthesis Investigators. Five-year report of a multicenter controlled clinical trial of open versus endovascular treatment of abdominal aortic aneurysms. J Vasc Surg. 2007;45:885–890.
10.
CarpenterJP. The Powerlink bifurcated system for endovascular aortic aneurysm repair: four-year results of the US multicenter trial. J Cardiovasc Surg (Torino). 2006;47:239–243.
11.
JacobowitzGRLeeAMRilesTS. Immediate and late explantation of endovascular aortic grafts: the Endovascular Technologies experience. J Vasc Surg. 1999;29:309–316.
12.
CarpenterJPBaumRABarkerCF. Durability of benefits of endovascular versus conventional abdominal aortic aneurysm repair. J Vasc Surg. 2002;35:222–228.
13.
LydenSPMcNamaraJMSternbachY. Technical considerations for late removal of aortic endografts. J Vasc Surg. 2002;36:674–678.
14.
KelsoRLLydenSPButlerB. Late conversion of aortic stent grafts. J Vasc Surg. 2009;49:589–595.
15.
MoulakakisKGDalainasIMylonasS. Conversion to open repair after endografting for abdominal aortic aneurysm: a review of causes, incidence, results, and surgical techniques of reconstruction. J Endovasc Ther. 2010;17:694–702.
16.
ChaarCIEidRParkT. Delayed open conversions after endovascular abdominal aortic aneurysm repair. J Vasc Surg. 2012;55:1562–1569.
17.
PitouliasGASchulteSDonasKP. Secondary endovascular and conversion procedures for failed endovascular abdominal aortic aneurysm repair: can we still be optimistic?Vascular. 2009;17:15–22.
18.
FariesPLCadotHAgarwalG. Management of endoleak after endovascular aneurysm repair: cuffs, coils, and conversion. J Vasc Surg. 2003;37:1155–1161.
19.
NabiDMurphyEHPakJ. Open surgical repair after failed endovascular aneurysm repair: is endograft removal necessary?J Vasc Surg. 2009;50:714–721.
20.
MassucciMLauriDFaragliaV. Approach to the abdominal aorta: impairment of respiratory function after supraumbilical transverse and midline laparotomy. Ital J Surg Sci. 1989;19:247–253.
SpezialeFRuggieroMSbarigiaE. Factors influencing outcome after open surgical repair of juxtarenal abdominal aortic aneurysms. Vascular. 2010;18:141–146.
23.
EVAR trial participants. Endovascular aneurysm repair and outcome in patients unfit for open repair of abdominal aortic aneurysm (EVAR trial 2): randomised controlled trial. Lancet. 2005;365:2187–2192.
24.
MurphyEHSzetoWYHerdrichBJ. The management of endograft infections following endovascular thoracic and abdominal aneurysm repair. J Vasc Surg. 2013;58:1179–1185.
25.
MayJWhiteGHYuW. Conversion from endoluminal to open repair of abdominal aortic aneurysms: a hazardous procedure. Eur J Vasc Endovasc Surg. 1997;14:4–11.
26.
MayJWhiteGHarrisJP. Techniques for surgical conversion of aortic endoprosthesis. Eur J Vasc Endovasc Surg. 1999;18:284–289.
27.
AryaSColemanDMKnepperJ. Outcomes after late explantation of aortic endografts depend on indication for explantation. Ann Vasc Surg. 2013;27:865–873.
28.
LewWMooreW. Antibiotic-impregnated grafts for aortic reconstruction. Semin Vasc Surg. 2011;24:211–219.
RiccoJBAssadianO. Antimicrobial silver grafts for prevention and treatment of vascular graft infection. Semin Vasc Surg. 2011;24:234–241.
31.
DucasseECalistiASpezialeF. Aortoiliac stent graft infection: current problems and management. Ann Vasc Surg. 2004;18:521–526.
32.
FioraniPSpezialeFCalistiA. Endovascular graft infection: preliminary results of an international enquiry. J Endovasc Ther. 2003;10:919–927.
33.
FioraniPSpezialeFRizzoL. Long-term follow-up after in situ graft replacement in patients with aortofemoral graft infections. Eur J Vasc Endovasc Surg. 1997;14(suppl A):111–114.
34.
ThallerMCSelanLFioraniP. A comparative in vitro evaluation of different therapeutic protocols for vascular graft infections. Eur J Vasc Endovasc Surg. 1997;14(suppl A):35–37.
35.
SpezialeFRizzoLSbarigiaE. Bacterial and clinical criteria relating to the outcome of patients undergoing in situ replacement of infected abdominal aortic grafts. Eur J Vasc Endovasc Surg. 1997;13:127–133.
36.
EnglandDWSimmsMH. Recurrent aortoduodenal fistula: a final solution?Eur J Vasc Surg. 1990;4:427–429.
37.
ShahDMBuchbinderDLeatherRP. Clinical use of the seromuscular jejunal path for protection of the infected aortic stump. Am J Surg. 1983;146:198–202.
38.
SpezialeFRizzoLFaddaGF. Surgical approach for the treatment of secondary aortoenteric fistulae. Eur J Vasc Endovasc Surg. 1998;16:530–534.
39.
AntoniouGAKoutsiasSAntoniouSA. Outcome after endovascular stent graft repair of aortoenteric fistula: a systematic review. J Vasc Surg. 2009;49:782–789.
